Prolonged Sevoflurane, Isoflurane and Halothane Anaesthesia in Oxygen Using Rebreathing or Non-rebreathing System in Cats

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 45, Issue 9, 1998, Pages 559-575

  Hikasa, Y ^a   Yamashita, M ^b   Takase, K ^b   Ogasawara, S ^b  

^a TOTTORI UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FELIS CATUS;

EID: 2542592397     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0442.1998.tb00860.x     Document Type: Article

References (41)

1. AKAZAWA, S., R. SHIMIZU, H. KASUDA, K. NEMOTO, Y. YOSHIZAWA, and S. INOUE, 1988: Effects of sevoflurane on cardiovascular dynamics, coronary circulation and myocardial metabolism in dogs. J. Anesth. 2, 227-241.
2. BERNARD, J.-M., P. F. WOUTERS, M-F, DOURSOUT, B. FLORENCE, J. E. CHELLY, and R. G. MERIN, 1990: Effects of sevoflurane and isoflurane on cardiac and coronary dynamics in chronically instrumented dogs. Anesthesiology 72, 659-662.
3. COUSINS, M. J., and R. I. MAZZE, 1973; Methoxyflurane nephrotoxicity: a study of dose-response in man. J. Am. Med. Assoc. 225, 1611-1616.
4. DOI, M., and K. IKEDA, 1987: Respiratory effects of sevoflurane. Anesth. Analg. 66, 241-244.
5. DOI, M., T. KATOH, T. TAKII, M. YURA, and K. IKEDA, 1987: The respiratory effects of sevoflurane in dogs. Jpn. J. Anesth. 36, 1053-1057.
6. DUNLOP, C. I., E. P. STEFFEY, M. F. MILLER, and M. J. WOLINER, 1987: Temporal effects of halothane and isoflurane in laterally recumbent ventilated male horses. Am. J. Vet. Res. 48, 1250-1255.
7. FOURCADE, H. E., C. P. LARSON Jr, R. F. HICKEY, S. H. BAHLMAN, and E. I. EGER II, 1972: Effects of time on ventilation during halothane and cyclopropane anaesthesia. Anesthesiology 36, 83-88.
8. FRINK, E. J., H. GHANTOUS, T. P. MALAN, S. MORGAN, J. FERNANDO, A. J. GANDOLFI, and B. R. BROWN, 1992a: Plasma inorganic fluoride with sevoflurane anaesthesia: correlation with indices of hepatic and renal function. Anesth. Analg. 74, 231-235.
9. FRINK, E. J., S. E. MORGAN, A. COETZEE, P. F CONZEN, and B. R. BROWN, 1992b: The effects of sevoflurane, halothane, enflurane, and isoflurane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs. Anesthesiology 76, 85-90.
10. GAUTIER, H., M. BONORA, and D. ZAOUI, 1987: Influence of halothane on control of breathing in intact and decerebrated cats. J. Appl. Physiol. 63, 546-553.
11. GINGERICH, R., P. H. WRIGHT, and R. R. PARADISE, 1980: Effects of halothane on glucose-stimulated insulin secretion and glucose oxidation in isolated rat pancreatic islets. Anesthesiology 53, 219-222.
12. GRAKDY, J. L., D. S. HODGSON, C. I. DUNLOP, C. R. CURTIS, and R. B. HEATH, 1989: Cardiopulmonary effects of halothane anaesthesia in cats. Am. J. Vet. Res. 50, 1729-1732.
13. HALTER, J. B., and A. E. PFLUNG, 1980: Relationship of impaired insulin secretion during surgical stress to anaesthesia and catecholamine release. J. Clin. Endocrinol. Metab. 51, 1093-1097.
14. HANAKI, C., K., FUJII, M. MORIO, and T. TASHIMA, 1987: Decomposition of sevoflurane by sodalime. Hiroshima J. Med. Sci. 36, 61-67.
15. HARTSFIELD, S. M., and D. C. SAWYER, 1976: Cardiopulmonary effects of rebreathing and nonrebreathing systems during halothane anaesthesia in the cat. Am. J. Vet. Res. 37, 1461-1466.
16. HIKASA, Y., H. KAWANABE, K. TAKASE, and S. OGASAWARA, 1996a: Comparisons of sevoflurane, isoflurane and halothane anaesthesia in spontaneously breathing cats. Vet. Surg. 25, 234-243.
17. HIKASA, Y., C. OKABE, K. TAKASE, and S. OGASAWARA, 1996b: Ventricular arrhythmogenic dose of adrenaline during sevoflurane, isoflurane, and halothane anaesthesia either with or without ketamine and thiopentone in cats. Res. Vet. Sci. 60, 134-137.
18. HIKASA, Y., T. YOSHIKAI, K. TAKASE, and S. OGASAWARA, 1997: Comparisons of prolonged sevoflurane, isoflurane, and halothane anaesthesia combined with nitrous oxide in spontaneously breathing cats. J. Vet. Med. A44, 427-442.
19. HOLADAY, D. A., and F. R. SMITH, 1981: Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 54, 100-106.
20. IMAMURA, S., and K. IKEDA, 1987: Comparison of the epinephrine-induced arrhythmogenic effect of sevoflurane with isoflurane and halothane. J. Anesth. 1, 62-68.
21. INGWERSEN, W., D. G. ALLEN, D. H. DYSON, P. J. PASCOE, and M. R. O'GRANDY, 1988: Cardiopulmonary effects of a halothane/oxygen combination in healthy cats. Can J. Vet. Res. 52, 386-391.
22. KAZAMA, T , and K. IKEDA, 1985: Comparison of MAC and the rate of rise of alveolar concentration of sevoflurane with halothane and isoflurane in the dog. Anesthesiology 68, 435-437.
23. KAZAMA, T., and K. IKEDA, 1988: The comparative cardiovascular effects of sevoflurane with halothane and isoflurane. J. Anesth. 2, 63-68.
24. MANOHAR, M., and C. M. PARKS, 1984: Porcine systemic and regional organ blood flow during 1.0 and 1.5 minimum alveolar concentrations of sevoflurane anaesthesia without and with 50% nitrous oxide. J. Pharmacol. Exp. Ther. 231, 640-648.
25. MARTIS, L., S. LYNCH, M. D. NAPOLI, and E. F. WOODS, 1981: Biotransformation of sevoflurane in dogs and rats. Anesth. Analg. 60, 186-191.
26. MAZZARELLI, M., J. P. HABERER, N. JASPAR, and G. MISEROCCHI, 1979: Mechanism of halothane induced tachypnea in cats. Anesthesiology 51, 522-527.
27. MITCHELL, A. R., 1994: Physiology, In: L. W. HALL and P. M. TAYLOR (eds.), Anaesthesia of the Cat. Baillière Tindall, UK. pp. 12-39.
28. MIDDLETON, D. J., J. E. ILKIW, and A. D. J. WATSON, 1981: Arterial and venous blood gas tensions in clinically healthy cats. Am. J. Vet. Res 42, 1609-1611.
29. NISHINO, T., and Y. HORDA, 1980: Changes in the respiratory pattern induced by halothane in the cat. Br. J. Anaesth. 52, 1191-1196.
30. OYAMA, T., T. MURAKAWA, and A. MATSUKI, 1989: Endocrine evaluation of sevoflurane, a new inhalation anaesdietic agent. Acta Anaesthesiol. Belg. 40, 269-274.
31. RICHARDSON, D. W., A. J. WASSERMAN, and J. L. PATTERSON, 1961: General and regional circulatory responses to change in blood pH and carbon dioxide tension. J. Clin. Invest. 40, 31-43.
32. STEFFEY, E. P., 1994: Inhalation anaesthesia. In: L. W. HALL and P. M. TAYLOR (eds.), Anaesthesia of the Cat. Baillière Tindall, UK. pp. 157-193.
33. STEFFEY, E. P., T. B. FARVER, and M. J. WOLINER, 1987a: Cardiopulmonary function during 7 h of constant-dose halothane and methoxyflurane. J. Appl. Physiol. 63, 1351-1359.
34. STEFFEY, E. P., D. S. HODGSON, C. I. DUNLOP, M. F. MILLER, M. J. WOLINER, R. B. HEATH, and J. GRANDY, 1987b: Cardiopulmonary function during 5 hours of constant-dose isoflurane in laterally recumbent, spontaneously breathing horses. J. Vet. Pharmacol. Ther. 10, 290-297.
35. STEFFEY, E. P., and D. HOWLAND, 1977: Isoflurane potency in the dog and cat. Am. J. Vet. Res. 38, 1833-1836.
36. STEFFEY, E. P., and D. HOWLAND, 1978: Potency of enflurane in dogs: comparison with halothane and isoflurane. Am. J. Vet. Res. 39, 573-577.
37. STEFFEY, E. P., A. B. KELLY, and M. J. WOLINER, 1987c: Time-related responses of spontaneously breathing, laterally recumbent horses to prolonged anaesthesia with halothane. Am. J. Vet. Res. 48, 952-957.
38. STRUM, D. P., and E, I. EGER II,1987: Partition coefficients for sevoflurane in human blood, saline, and olive oil. Anesth. Analg. 66, 654-656.
39. STRUM, D. P., E. I. EGER II, B. H. JOHNSON, E. P. STEFFEY, and L. D. FERRELL, 1987: Toxicity of sevoflurane in rats. Anesth. Analg. 66, 769-773.
40. TAKEDA, R., and A. HAJI, 1993: Cellular effects of isoflurane on bulbar respiratory neurons in decerebrate cats. Jpn. J. Pharmacol. 62, 57-65.
41. WALLIN, R. F., B. M. REGAN, M. D. NAPOLI, and I. J. STERN, 1975: Sevoflurane: a new inhalation anesthetic agent. Anesth. Analg. 54, 758-766.